Mojgan Masoodi
Overview
Explore the profile of Mojgan Masoodi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Masoodi M, Gastaldelli A, Hyotylainen T, Arretxe E, Alonso C, Gaggini M, et al.
Nat Rev Gastroenterol Hepatol
. 2021 Sep;
18(12):835-856.
PMID: 34508238
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is often associated with aspects of metabolic syndrome. Despite its prevalence and the importance of...
12.
Clark C, Dayon L, Masoodi M, Bowman G, Popp J
Alzheimers Res Ther
. 2021 Apr;
13(1):71.
PMID: 33794997
Background: Multiple pathophysiological processes have been described in Alzheimer's disease (AD). Their inter-individual variations, complex interrelations, and relevance for clinical manifestation and disease progression remain poorly understood. We hypothesize that...
13.
Cioccari L, Luethi N, Masoodi M
Front Immunol
. 2020 Dec;
11:599853.
PMID: 33324417
A dysregulated response to systemic inflammation is a common pathophysiological feature of most conditions encountered in the intensive care unit (ICU). Recent evidence indicates that a dysregulated inflammatory response is...
14.
Sonnay S, Christinat N, Thevenet J, Wiederkehr A, Chakrabarti A, Masoodi M
Biomedicines
. 2020 Nov;
8(11).
PMID: 33182557
The utilization of alternative energy substrates to glucose could be beneficial in traumatic brain injury (TBI). Recent clinical data obtained in TBI patients reported valine, β-hydroxyisobutyrate (ibHB) and 2-ketoisovaleric acid...
15.
Christinat N, Valsesia A, Masoodi M
Biomolecules
. 2020 Jul;
10(7).
PMID: 32679761
The development of high throughput assays for assessing lipid metabolism in metabolic disorders, especially in diabetes research, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH), provides a reliable tool...
16.
Valsesia A, Chakrabarti A, Hager J, Langin D, Saris W, Astrup A, et al.
Sci Rep
. 2020 Jun;
10(1):9236.
PMID: 32514005
Weight loss aims to improve glycemic control in obese but strong variability is observed. Using a multi-omics approach, we investigated differences between 174 responders and 201 non-responders, that had lost...
17.
Chakrabarti A, Eiden M, Morin-Rivron D, Christinat N, Monteiro J, Kaput J, et al.
Clin Nutr
. 2019 Nov;
39(7):2211-2219.
PMID: 31677804
Background: Micronutrient supplementation has been extensively explored as a strategy to improve health and reduce risk of chronic diseases. Fat-soluble vitamins like A and E with their antioxidant properties and...
18.
Sonnay S, Chakrabarti A, Thevenet J, Wiederkehr A, Christinat N, Masoodi M
Front Physiol
. 2019 Jun;
10:657.
PMID: 31214043
Medium-chain triglyceride (MCT) ketogenic diets increase ketone bodies, which are believed to act as alternative energy substrates in the injured brain. Octanoic (C8:0) and decanoic (C10:0) acids, which produce ketone...
19.
Eiden M, Christinat N, Chakrabarti A, Sonnay S, Miroz J, Cuenoud B, et al.
EBioMedicine
. 2019 Jun;
44:607-617.
PMID: 31202815
Background: Traumatic brain injury (TBI) is recognized as a metabolic disease, characterized by acute cerebral glucose hypo-metabolism. Adaptive metabolic responses to TBI involve the utilization of alternative energy substrates, such...
20.
Chouinard-Watkins R, Lacombe R, Metherel A, Masoodi M, Bazinet R
Mol Nutr Food Res
. 2019 Feb;
63(9):e1801224.
PMID: 30768751
Scope: Docosahexaenoic acid (DHA, 22:6n-3) is crucial for optimal neuronal development and function, but the brain has a poor capacity to synthesize this fatty acid. When consumed acutely esterified to...